Previous studies have reported ABCB1, SCN1A, SCN2A, ATP1A2, and ATP1A3 as genetic factors associated with drug resistance in epileptic patients.24–27 However, only a few studies have evaluated the relationship between ABCC2 polymorphisms and drug resistance in patients with epilepsy. Here, SCN1A is linked to epilepsy.